Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Nov 21, 2014; 20(43): 16079-16094
Published online Nov 21, 2014. doi: 10.3748/wjg.v20.i43.16079
Published online Nov 21, 2014. doi: 10.3748/wjg.v20.i43.16079
Studied subjects | Probiotic | Duration of treatment | Effects | Ref. |
C57BL/6J mice | Lactobacillus rhamnosus PL60 | 8 wk | ↓body weight gain, white adipose tissue, hepatic steatosis | [106] |
C57BL/6J mice | Lactobacillus plantarum PL62 | 8 wk | ↓body weight, visceral adipose tissue, serum glucose levels | [107] |
Sprague-Dawley rats | Lactobacillus gasseri SBT2055 | 4 wk | ↓adipocyte size, leptin levels | [108] |
No significant changes in serum glucose and lipids levels, and liver lipids levels | ||||
Zucker diabetic fatty rats | Lactobacillus fermentum NCIMB 5221 | 8 wk | ↓fasting insulin levels, insulin resistance, serum triglycerides and LDL cholesterol levels, atherosclerosis | [109] |
↑HDL cholesterol levels | ||||
Male Kunming mice | L. plantarum CAI6, L. plantarum SC4 | 28 d | ↓serum total and LDL cholesterol levels, LDL/HDL cholesterol ratio, triglycerides levels, hepatic steatosis | [110] |
↑serum HDL cholesterol, hepatic anti-oxidant Nrf-2 mediated response | ||||
C57BL/6J mice | Lactobacillus rhamnosus GG | 13 wk | ↓liver and mesenteric adipose tissue, weight gain | [111] |
↑glucose tolerance, gluconeogenesis, fatty acids oxidation | ||||
Apoe-/- mice | Lactobacillus reuteri ATCC PTA 4659 (ATCC), DSM 17938 (DSM), L6798 | 12 wk | ↓body weight gain, insulin levels, hepatic steatosis | [112] |
↑fatty acids oxidation | ||||
C57BL/6 mice | Lactobacillus plantarum strain No. 14 | 11 wk | ↓adipocyte size, white adipose tissue, serum leptin and total cholesterol levels | [113] |
C57B/6J mice | Lactobacillus paracasei ssp paracasei F19 | 10 d | ↓body weight | [114] |
↑triglyceride load of the lipoprotein VLDL, angiopoietin-like 4 protein that ↓fatty storage | ||||
GF and NMF mice | Lactobacillus paracasei ssp paracasei F19 or Lactobacillus acidophilus NCFB 1748 | 10 d | ↑adipsin, adiponectin, fatty acids oxidation | [115] |
Improvement of efficacy of intestinal immunological barrier | ||||
↓resistine like β |
- Citation: Festi D, Schiumerini R, Eusebi LH, Marasco G, Taddia M, Colecchia A. Gut microbiota and metabolic syndrome. World J Gastroenterol 2014; 20(43): 16079-16094
- URL: https://www.wjgnet.com/1007-9327/full/v20/i43/16079.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i43.16079